BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

TYRX 

1 Deer Park Drive
Suite G
Monmouth Junction  New Jersey  08852  U.S.A.
Phone: 732-246-8676 Fax: 732-246-8677


SEARCH JOBS








 Company News
Medtronic, Inc. (MDT) Scoops Up NJ-Based TYRX For $160 Million 1/7/2014 7:39:09 AM    More...
FDA Clears TYRX Antibacterial Envelope For Use With Spinal Cord Neuromodulators 12/4/2013 6:38:26 AM    More...
TYRX Announces First U.S. Implantation of AIGISRx® R Fully Bioresorbable Antibacterial Envelope 8/7/2013 9:45:51 AM    More...
TYRX Receives FDA Clearance for AIGISRx® Neuro Antibacterial Envelope 7/23/2013 7:06:16 AM    More...
FDA Clears New Version of TYRX's Infection-Fighting Pacemaker Sleeve 7/9/2013 6:50:15 AM    More...
Zero Infections in High-Risk Cardiac Device Replacements Reported With Use of TYRX Antibacterial Envelope 6/26/2013 11:22:04 AM    More...
Extremely Low 90-Day Cardiac Device Infection Rates With TYRX Antibacterial Envelope Use 5/13/2013 8:11:56 AM    More...
TYRX Release: Nearly 50% of Patients With Cardiac Device Infections Don’t Survive Beyond Three Years 5/10/2013 12:42:40 PM    More...
Health Canada Clears TYRX' New AIGISRx® R 1/31/2013 7:25:51 AM    More...
GE Capital Agents $8.5 Million Senior Secured Credit Facility for Medtech Company TYRX 1/29/2013 10:06:19 AM    More...
1234567

//-->